In conversation with... Paula Ghaneh

from Listen to The Lancet Gastroenterology & Hepatology · host The Lancet

Paula Ghaneh (University of Liverpool) discusses the ESPAC5 randomised controlled trial of short-course neoadjuvant therapy compared with immediate surgery for patients with borderline resectable pancreatic ductal adenocarcinoma.

Episode metadata supplied by the publisher feed · Published Jan 24, 2023

Embed this episode

Attribution link and audio player

NOW PLAYING

In conversation with... Paula Ghaneh

0:00 20:20

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Listen to The Lancet Gastroenterology & Hepatology?

This episode is 20 minutes long.

When was this Listen to The Lancet Gastroenterology & Hepatology episode published?

This episode was published on January 24, 2023.

Can I download this Listen to The Lancet Gastroenterology & Hepatology episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!